Bliwise, D. L., W. F. Seidel, S. A. Cohen, N. G. Bliwise, and W. C. Dement. 1988. Profile of mood state changes during and after 5 weeks of nightly triazolam administration. Journal of Clinical Psychiatry 49(9):349-355.

Bonnet, M. H., and D. L: Arand. 1990. The use of triazolam in older patients with periodic leg movements, fragmented sleep and daytime sleepiness. Journal of Gerontology 45(4):139-144.

Bonnet, M. H., and D. L. Arand. 1991. Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness. Aging (Milano) 3:313-324.

Chaudoir, P. J., N. L. Bodkin, J. O'Donnell, A. Anderson, and R. L. Holland. 1990. A comparative study of zopiclone and triazolam in patients with insomnia. International Clinical Psychopharmacology 5(Suppl. 2):21-27.


Derry, C. L., P. D. Kroboth, A. L. Pittenger, F. J. Kroboth, S. E. Corey, and R. B. Smith. 1995. Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men. Journal of Clinical Psychopharmacology 15:197-205.

Ducic, I., G. Puia, S. Vicini, and E. Costa. 1993. Triazolam is more efficacious than diazepam in a broad spectrum of recombinant GABAA receptors. European Journal of Pharmacology 244:29-35.


Eberts, F. S., Jr., Y. Philopoulos, L. M. Reineke, and R. W. Vliek. 1981. Triazolam disposition. Clinical Pharmacology and Therapeutics 29:81-93.

Elie, R., M. Frenay, P. Le Morvan, and J. Bourgouin. 1990. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. International Clinical Psychopharmacology 2(Suppl.):39-46.


Faure-Halley, C., D. Graham, S. Arbilla, and S. Z. Langer. 1993. Expression and properties of recombinant alpha 1 beta 2 gamma 2 and alpha 5 beta 2 gamma 2 forms of the rat GABAA receptor. European Journal of Pharmacology 246:283-287.

Fernandez-Guardiola, A., and J. L. Jurado. 1981. The effect of triazolam on insomniac patients using a laboratory sleep evaluation. Current Therapeutics Research 29:950-958.

Fleming, J. A., D. J. McClure, C. Mayes, R. Phillips, and J. Bourgouin. 1990. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia. International Clinical Psychopharmacology 2(Suppl.):29-37.


Gales, B. J., and S. M. Menard. 1995. Relationship between the administration of selected medications and falls in hospitalized elderly patients. Annals of Pharmacotherapy 29(4):354-358.

Gibbons, R. D., D. R. Hedeker, I. Elkin, C. Waternaux, H. C. Kraemer, J. B. Greenhouse, M. T. Shea, S. D. Imber, S. M. Sotsky, and J. T. Watkins. 1993. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Archives of General Psychiatry 50:739-750.

Gibbons, R. D., D. R. Hedeker, S.C. Charles, and P. Frisch. 1994. A random-effects probit model for predicting medical malpractice claims. Journal of the American Statistical Association 89:760-767.

Gillin, J. C., C. L. Spinweber, and L. C. Johnson. 1989. Rebound insomnia: a critical review. Journal of Clinical Psychopharmacology 9:161-172.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement